Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.6800
-0.0200 (-2.86%)
Jul 29, 2025, 2:55 PM AEST

Argenica Therapeutics Company Description

Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury.

Argenica Therapeutics Limited was incorporated in 2019 and is headquartered in Nedlands, Australia.

Argenica Therapeutics Limited
Argenica Therapeutics logo
CountryAustralia
Founded2019
IndustryBiotechnology
SectorHealthcare
CEOLiz Dallimore

Contact Details

Address:
117 Broadway
Nedlands, 6009
Australia
Phone61 8 9329 3396
Websiteargenica.com.au

Stock Details

Ticker SymbolAGN
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000150328
SIC Code2834

Key Executives

NamePosition
Dr. Liz Dallimore B.Sc., M.B.A., Ph.D.Chief Executive Officer, MD and Director
Emma WaldonChief Financial Officer and Company Secretary
Prof. Bruno Philip MeloniChief Scientific Officer